Affiliation:
1. Department of Sports Teaching, Shanghai University of Medicine and Health Sciences, Shanghai, China
2. Department of Healthcare Information and Management, School of Health Technology, Ming Chuan University, Taoyuan, Taiwan
3. Graduate Institute of Sport Coaching Science, College of Kinesiology and Health, Chinese Culture University, Taipei, Taiwan
4. Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University, Taipei, Taiwan.
Abstract
Sarcopenia increases disability, hospital stays, readmissions, and mortality in older adults. Antioxidative nutrients and fatty acids consumption may help maintain muscle mass by reducing oxidative stress. This study aims to assess the association between antioxidant and fatty acid intake and low muscle mass in community-dwelling older people. This retrospective analysis used data from the National Health and Nutrition Examination Survey from 1999 to 2004. Participants ≥ 60 years with information on muscle mass measured by Dual energy X-ray absorptiometry (DXA) were included. Appendicular skeletal muscle mass was assessed. Associations between antioxidants and fatty acids intake, and low muscle mass were evaluated using logistic regressions. 3648 (1748 men and 1900 women) were included. The prevalence of low muscle mass was 41% and 26% among men and women ≥ 75 years, and 45.2% and 28.4% among obese men and women. In obese males, a natural-log-unit increase of vitamin A (aOR = 0.806, 95% CI: 0.652–0.996), vitamin C (aOR = 0.878, 95% CI: 0.779–0.990), selenium intake (aOR = 0.716, 95% CI: 0.517–0.993), and higher saturated fatty acids (aOR = 0.956, 95% CI: 0.915–0.998) and monounsaturated fatty acids (aOR = 0.959, 95% CI: 0.925–0.994) intake were associated with decreased odds for low muscle mass. Among obese females, a natural-log-unit increase of vitamin E (P = .036), vitamin B12 (P = .014), total folate (P = .015), zinc (P = .005), and selenium intake (P = .018) were associated with increased odds of low muscle mass, whereas higher saturated fatty acids (P < .001), monounsaturated fatty acids (P = .001), and polyunsaturated fatty acids intake (P = .006) were associated with decreased odds for low muscle mass. Antioxidants (vitamin A, C, E, B6, B12, total folate, zinc, magnesium, selenium) intake does not consistently relate to low muscle mass across age and sex. Higher intake of saturated, monounsaturated, and polyunsaturated fatty acids are independently associated with reduced likelihood of low muscle mass in both obese older men and women.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference40 articles.
1. Epidemiology of sarcopenia: prevalence, risk factors, and consequences.;Yuan;Metabolism,2023
2. The developmental origins of sarcopenia.;Sayer;J Nutr Health Aging,2008
3. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.;Studenski;J Gerontol A Biol Sci Med Sci,2014
4. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People.;Cruz-Jentoft;Age Ageing,2010
5. Sarcopenia: an undiagnosed condition in older adults current consensus definition: prevalence, etiology, and consequences International working group on sarcopenia.;Fielding;J Am Med Dir Assoc,2011